The value of syntax score to predict new-onset atrial fibrillation in patients with acute coronary syndrome.


Journal

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc
ISSN: 1542-474X
Titre abrégé: Ann Noninvasive Electrocardiol
Pays: United States
ID NLM: 9607443

Informations de publication

Date de publication:
07 2019
Historique:
received: 01 11 2018
revised: 04 12 2018
accepted: 16 12 2018
pubmed: 8 1 2019
medline: 3 6 2020
entrez: 8 1 2019
Statut: ppublish

Résumé

New-onset atrial fibrillation (NOAF) has been associated with poor outcome in patients with acute coronary syndromes (ACS). Also, Syntax score (SS) is a scoring system that is derived from angiographic images and is associated with long-term mortality and major adverse cardiac events. In this study, we aimed to assess the relationship between SS and NOAF with known predictors of atrial fibrillation. In a prospective, single-center, cross-sectional study, 692 patients who were diagnosed with coronary artery disease for the first time were enrolled consecutively. NOAF was defined as atrial fibrillation, which was documented after hospital admission. SS was calculated by a computer software. Multivariable logistic regression analyzes were used to detect the relationship between variables and NOAF. New-onset atrial fibrillation was detected in 82 patients (11.8%). Patients with NOAF had higher SS (22, interquartile range 18.3-25.1, vs. 12, interquartile range 7-19.5, p < 0.001). According to multivariable logistic regression analysis for NOAF, SS were independently and significantly associated (OR, 1.103; 95% confidence interval, 1.047-1.163; p < 0.001). Other independent predictors of NOAF were TIMI flow <3, C reactive protein, left ventricular ejection fraction, left atrial volume index and E/E' ratio. The optimal cut-off value for SS was 18 for the development of NOAF with 82% sensitivity and 68% specificity (area under the curve: 0.795, 95% confidence interval 0.749-0.841, p < 0.001). Syntax score may be helpful to identify for patients who would develop atrial fibrillation in the setting of ACS.

Sections du résumé

BACKGROUND AND AIM
New-onset atrial fibrillation (NOAF) has been associated with poor outcome in patients with acute coronary syndromes (ACS). Also, Syntax score (SS) is a scoring system that is derived from angiographic images and is associated with long-term mortality and major adverse cardiac events. In this study, we aimed to assess the relationship between SS and NOAF with known predictors of atrial fibrillation.
METHODS
In a prospective, single-center, cross-sectional study, 692 patients who were diagnosed with coronary artery disease for the first time were enrolled consecutively. NOAF was defined as atrial fibrillation, which was documented after hospital admission. SS was calculated by a computer software. Multivariable logistic regression analyzes were used to detect the relationship between variables and NOAF.
RESULTS
New-onset atrial fibrillation was detected in 82 patients (11.8%). Patients with NOAF had higher SS (22, interquartile range 18.3-25.1, vs. 12, interquartile range 7-19.5, p < 0.001). According to multivariable logistic regression analysis for NOAF, SS were independently and significantly associated (OR, 1.103; 95% confidence interval, 1.047-1.163; p < 0.001). Other independent predictors of NOAF were TIMI flow <3, C reactive protein, left ventricular ejection fraction, left atrial volume index and E/E' ratio. The optimal cut-off value for SS was 18 for the development of NOAF with 82% sensitivity and 68% specificity (area under the curve: 0.795, 95% confidence interval 0.749-0.841, p < 0.001).
CONCLUSION
Syntax score may be helpful to identify for patients who would develop atrial fibrillation in the setting of ACS.

Identifiants

pubmed: 30615236
doi: 10.1111/anec.12622
pmc: PMC6931656
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e12622

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Références

Circulation. 1996 Nov 15;94(10):2373-80
pubmed: 8921776
Heart Rhythm. 2011 Jul;8(7):955-60
pubmed: 21338715
Eur J Heart Fail. 2006 Oct;8(6):591-8
pubmed: 16507350
Circ J. 2016 Jun 24;80(7):1615-23
pubmed: 27210266
Ann Noninvasive Electrocardiol. 2019 Jul;24(4):e12622
pubmed: 30615236
J Am Soc Echocardiogr. 2005 Dec;18(12):1440-63
pubmed: 16376782
Am Heart J. 2013 Nov;166(5):855-63.e3
pubmed: 24176441
J Cardiovasc Pharmacol. 2008 Oct;52(4):306-13
pubmed: 18791466
Am J Cardiol. 2007 Sep 1;100(5):753-7
pubmed: 17719315
J Am Coll Cardiol. 1997 Aug;30(2):406-13
pubmed: 9247512
Am Heart J. 2011 Apr;161(4):771-81
pubmed: 21473978
J Am Coll Cardiol. 2012 Dec 4;60(22):2263-70
pubmed: 23194937
Am J Cardiol. 2009 Jul 15;104(2):169-74
pubmed: 19576341
J Am Coll Cardiol. 2013 Jan 29;61(4):e78-e140
pubmed: 23256914
Am J Cardiol. 2003 Nov 1;92(9):1031-6
pubmed: 14583352
Circulation. 2007 Dec 4;116(23):2702-8
pubmed: 18025528
Ann Noninvasive Electrocardiol. 2018 Mar;23(2):e12504
pubmed: 28975725
Am J Cardiol. 2002 Dec 15;90(12):1284-9
pubmed: 12480035
Am J Cardiol. 2003 Nov 15;92(10):1150-4
pubmed: 14609587
J Am Coll Cardiol. 2014 Dec 23;64(24):e139-e228
pubmed: 25260718
Circulation. 2000 Mar 7;101(9):969-74
pubmed: 10704162
Am J Cardiol. 2011 Jun 15;107(12):1738-43
pubmed: 21497781
Eur Heart J. 1999 May;20(10):748-54
pubmed: 10329066
Eur J Echocardiogr. 2010 Aug;11(7):602-7
pubmed: 20304839
Heart. 2001 Nov;86(5):527-32
pubmed: 11602545
Eur Heart J. 2005 Feb;26(4):350-6
pubmed: 15618041
Am J Cardiol. 2014 Jan 15;113(2):236-42
pubmed: 24176066
Am J Cardiol. 1999 Oct 1;84(7):829-32
pubmed: 10513783
N Engl J Med. 2005 Apr 21;352(16):1685-95
pubmed: 15843671
Am J Cardiol. 2009 Nov 15;104(10):1317-23
pubmed: 19892044
Eur Heart J. 2010 Oct;31(19):2369-429
pubmed: 20802247
Am J Cardiol. 2001 Jul 15;88(2):160-2, A5
pubmed: 11448413
Circulation. 2003 Apr 15;107(14):1930-6
pubmed: 12668526
Int J Cardiol. 2011 Jan 7;146(1):28-31
pubmed: 19570585
EuroIntervention. 2005 Aug;1(2):219-27
pubmed: 19758907
Card Electrophysiol Rev. 2003 Sep;7(3):201-7
pubmed: 14739713

Auteurs

Omer Faruk Cirakoglu (OF)

Department of Cardiology, Trabzon Ahi Evren Training and Research Hospital, University of Health Science, Trabzon, Turkey.

Ahmet Oğuz Aslan (AO)

Department of Cardiology, Trabzon Ahi Evren Training and Research Hospital, University of Health Science, Trabzon, Turkey.
Department of Cardiology, Akçaabat Haçkalı Baba State Hospital, Trabzon, Turkey.

Ali Riza Akyuz (AR)

Department of Cardiology, Trabzon Ahi Evren Training and Research Hospital, University of Health Science, Trabzon, Turkey.

Selim Kul (S)

Department of Cardiology, Trabzon Ahi Evren Training and Research Hospital, University of Health Science, Trabzon, Turkey.

Sinan Şahin (S)

Department of Cardiology, Trabzon Ahi Evren Training and Research Hospital, University of Health Science, Trabzon, Turkey.

Levent Korkmaz (L)

Department of Cardiology, Trabzon Ahi Evren Training and Research Hospital, University of Health Science, Trabzon, Turkey.

Muhammet Raşit Sayın (MR)

Department of Cardiology, Trabzon Ahi Evren Training and Research Hospital, University of Health Science, Trabzon, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH